By immunohistochemical detection of the expression of CD98, β1-integrin-A and Ki-67 in human HCC specimens, we found that the expression levels of these molecules were upregulated and correlated with cancer progression and malignancy in HCC patients (Figure 5). The gene discussed is MKI67; the disease is hepatocellular carcinoma.